{"id":"https://openalex.org/W7108463592","doi":"https://doi.org/10.1182/blood-2025-1765","title":"Dissecting pirtobrutinib resistance in Mantle Cell Lymphoma through single-cell multi-omics","display_name":"Dissecting pirtobrutinib resistance in Mantle Cell Lymphoma through single-cell multi-omics","publication_year":2025,"publication_date":"2025-11-03","ids":{"openalex":"https://openalex.org/W7108463592","doi":"https://doi.org/10.1182/blood-2025-1765"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2025-1765","doi":"https://doi.org/10.1182/blood-2025-1765","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2025-1765","pdf_url":"https://ashpublications.org/blood/article-pdf/146/Supplement 1/1765/2447817/blood-4512-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/146/Supplement 1/1765/2447817/blood-4512-main.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Fangfang Yan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fangfang Yan","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yang Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yang Liu","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Heng-Huan Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heng-Huan Lee","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Wei Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Wang","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Joseph McIntosh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph McIntosh","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yijing Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yijing Li","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jovanny Vargas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jovanny Vargas","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yue Fei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yue Fei","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lukas Simon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lukas Simon","raw_affiliation_strings":["2Baylor College of Medicine, Therapeutic Innovation Center, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Baylor College of Medicine, Therapeutic Innovation Center, Houston, United States","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100438316","display_name":"Michael L. Wang","orcid":"https://orcid.org/0000-0001-9748-5486","observed_orcids":["https://orcid.org/0000-0001-9748-5486"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Wang","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States","3The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"3The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"146","issue":"Supplement 1","first_page":"1765","last_page":"1765"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.9190000295639038},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.48399999737739563},{"id":"https://openalex.org/keywords/clonal-evolution","display_name":"clonal evolution","score":0.8899999856948853},{"id":"https://openalex.org/keywords/copy-number-alterations","display_name":"copy number alterations","score":0.8610000014305115},{"id":"https://openalex.org/keywords/chromosomal-gains","display_name":"chromosomal gains","score":0.38499999046325684},{"id":"https://openalex.org/keywords/rad21","display_name":"RAD21","score":0.7360000014305115},{"id":"https://openalex.org/keywords/cohesin","display_name":"cohesin","score":0.984000027179718},{"id":"https://openalex.org/keywords/gene-regulatory-networks","display_name":"gene regulatory networks","score":0.6700000166893005},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.9480000138282776},{"id":"https://openalex.org/keywords/chromatin-accessibility","display_name":"chromatin accessibility","score":0.7699999809265137},{"id":"https://openalex.org/keywords/epigenetic-reprogramming","display_name":"epigenetic reprogramming","score":0.7390000224113464},{"id":"https://openalex.org/keywords/non-genetic-resistance","display_name":"non-genetic resistance","score":0.578000009059906},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.7494000196456909},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.5927000045776367},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5543000102043152},{"id":"https://openalex.org/C83640560","wikidata":"https://www.wikidata.org/wiki/Q180951","display_name":"Chromatin","level":3,"score":0.5367000102996826},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.5291000008583069},{"id":"https://openalex.org/C51679486","wikidata":"https://www.wikidata.org/wiki/Q380546","display_name":"DNA sequencing","level":3,"score":0.478300005197525},{"id":"https://openalex.org/C77255625","wikidata":"https://www.wikidata.org/wiki/Q402093","display_name":"Reprogramming","level":3,"score":0.4456000030040741},{"id":"https://openalex.org/C120821319","wikidata":"https://www.wikidata.org/wiki/Q1501491","display_name":"Copy-number variation","level":4,"score":0.42719998955726624},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.40959998965263367},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.4025000035762787},{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.3749000132083893},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.3596999943256378},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.3553999960422516},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.33169999718666077},{"id":"https://openalex.org/C55548728","wikidata":"https://www.wikidata.org/wiki/Q1465102","display_name":"Gene dosage","level":4,"score":0.32659998536109924},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.32580000162124634},{"id":"https://openalex.org/C113968399","wikidata":"https://www.wikidata.org/wiki/Q7559241","display_name":"Somatic evolution in cancer","level":3,"score":0.31529998779296875},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.3131999969482422},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.30970001220703125},{"id":"https://openalex.org/C7602840","wikidata":"https://www.wikidata.org/wiki/Q746284","display_name":"Gene duplication","level":3,"score":0.2964000105857849},{"id":"https://openalex.org/C132917006","wikidata":"https://www.wikidata.org/wiki/Q5250436","display_name":"Deep sequencing","level":4,"score":0.28780001401901245},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.2865999937057495},{"id":"https://openalex.org/C53226629","wikidata":"https://www.wikidata.org/wiki/Q189967","display_name":"Karyotype","level":4,"score":0.2822999954223633},{"id":"https://openalex.org/C17757408","wikidata":"https://www.wikidata.org/wiki/Q4135516","display_name":"genomic DNA","level":3,"score":0.2806999981403351},{"id":"https://openalex.org/C76818968","wikidata":"https://www.wikidata.org/wiki/Q181940","display_name":"Sanger sequencing","level":4,"score":0.27000001072883606},{"id":"https://openalex.org/C187882448","wikidata":"https://www.wikidata.org/wiki/Q283478","display_name":"Complementary DNA","level":3,"score":0.26980000734329224},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.267300009727478},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.2671000063419342},{"id":"https://openalex.org/C166608930","wikidata":"https://www.wikidata.org/wiki/Q5169175","display_name":"Copy number analysis","level":5,"score":0.2669000029563904},{"id":"https://openalex.org/C2780737395","wikidata":"https://www.wikidata.org/wiki/Q18353741","display_name":"Epigenetic therapy","level":5,"score":0.26660001277923584},{"id":"https://openalex.org/C2776950831","wikidata":"https://www.wikidata.org/wiki/Q15635432","display_name":"Single-cell analysis","level":3,"score":0.26489999890327454},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.26190000772476196},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.258899986743927},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.25459998846054077},{"id":"https://openalex.org/C189206191","wikidata":"https://www.wikidata.org/wiki/Q222046","display_name":"Genomics","level":4,"score":0.2515000104904175}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2025-1765","doi":"https://doi.org/10.1182/blood-2025-1765","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2025-1765","pdf_url":"https://ashpublications.org/blood/article-pdf/146/Supplement 1/1765/2447817/blood-4512-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1182/blood-2025-1765","doi":"https://doi.org/10.1182/blood-2025-1765","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2025-1765","pdf_url":"https://ashpublications.org/blood/article-pdf/146/Supplement 1/1765/2447817/blood-4512-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6897851228713989}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7108463592.pdf","grobid_xml":"https://content.openalex.org/works/W7108463592.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"Although":[2],"the":[3,54,157,288,438,469],"non-covalent":[4],"BTK":[5],"inhibitor":[6],"Pirtobrutinib":[7],"(PBN)":[8],"has":[9],"demonstrated":[10,376],"clinical":[11],"efficacy":[12],"in":[13,188,197,317,356,403,409,447],"treating":[14],"relapsed":[15,69],"and":[16,28,47,68,97,110,130,152,166,184,192,215,231,236,253,261,276,304,364,385,429,455,468],"refractory":[17],"mantle":[18],"cell":[19,353],"lymphoma":[20],"(MCL)":[21],"patients,":[22,173],"resistance":[23,174,233,311,407,446,459],"emerges.":[24],"Inter-patient":[25],"genetic":[26,165],"variability":[27],"tumor":[29],"intrinsic":[30],"plasticity":[31,428],"give":[32],"rise":[33],"to":[34,45,81,93,102,169,243,264,299],"diverse":[35],"resistant":[36,131,190,199,328,357],"phenotypes":[37],"under":[38],"therapeutic":[39,244,340,480],"pressure,":[40],"posing":[41],"a":[42,134,284,294,323,331,338,349,398,406,418],"major":[43],"challenge":[44],"understanding":[46],"overcoming":[48,343],"drug":[49],"resistance.":[50,170,345,481],"Methods":[51],"To":[52],"dissect":[53],"molecular":[55],"dynamics":[56],"driving":[57,309],"PBN":[58,310,344,445],"resistance,":[59],"we":[60,347],"performed":[61],"integrative":[62,464],"single-cell":[63,77,85,98,441],"multi-omic":[64,442],"profiling":[65],"on":[66],"pre-treatment":[67],"primary":[70,448],"MCL":[71,125,449],"patient":[72],"samples.":[73],"Our":[74,161,463],"approach":[75],"combined":[76],"RNA":[78],"sequencing":[79,91,100],"(scRNA-seq)":[80],"measure":[82],"gene":[83,254,279],"expression,":[84],"assay":[86],"for":[87,342],"transposase-accessible":[88],"chromatin":[89,95],"using":[90,322],"(scATAC-seq)":[92],"assess":[94],"accessibility,":[96],"DNA":[99,302],"(scDNA-seq)":[101],"define":[103],"genomic":[104,229],"alterations,":[105],"including":[106],"copy":[107,179],"number":[108,180],"variations":[109],"clonal":[111,213],"architecture.":[112],"Results":[113],"We":[114,451],"analyzed":[115],"24":[116],"peripheral":[117],"blood":[118],"or":[119],"apheresis":[120],"samples":[121],"collected":[122],"from":[123,208],"13":[124],"patients":[126,225],"at":[127],"both":[128,164],"drug-sensitive":[129],"timepoints,":[132],"yielding":[133],"high-quality":[135],"dataset":[136,158],"of":[137,148,156,178,250,274,287,320,361,420,426,444,479],"113,143":[138],"single":[139],"cells.":[140],"Malignant":[141],"B":[142,352],"cells,":[143],"marked":[144],"by":[145,297],"high":[146],"levels":[147],"CD79A,":[149],"CCND1,":[150],"MS4A1,":[151],"IGHM,":[153],"comprised":[154],"50.28%":[155],"(n=":[159],"56,889).":[160],"analyses":[162,465],"revealed":[163,248],"non-genetic":[167,241],"routes":[168],"In":[171,222,433],"some":[172,224],"involved":[175],"stepwise":[176],"acquisition":[177],"gains,":[181],"with":[182,257,397,423,473],"2p":[183],"8q":[185],"gains":[186,195],"detected":[187],"early":[189],"clones":[191,200],"additional":[193],"1q":[194],"emerging":[196],"late-stage":[198],"(adjusted":[201,312],"p":[202,270,313,392],"<":[203,271,314,393],"0.05).":[204,272,315,394],"Polygenetic":[205],"tree":[206],"reconstructed":[207],"scDNA-seq":[209],"data":[210],"confirmed":[211],"this":[212,368],"evolution,":[214],"metaphase":[216],"karyotyping":[217],"further":[218],"validated":[219],"these":[220],"findings.":[221],"contrast,":[223],"showed":[226,382],"no":[227],"large-scale":[228],"alterations":[230],"developed":[232],"through":[234],"transcriptional":[235,333,454],"epigenetic":[237,456],"reprogramming":[238,363],"alone,":[239],"reflecting":[240],"adaptation":[242],"pressure.":[245],"Pathway":[246],"analysis":[247],"enrichment":[249],"NF-\u03baB":[251],"signaling":[252],"programs":[255],"associated":[256],"chromosome":[258],"segregation,":[259],"mitosis,":[260],"protein":[262],"localization":[263],"chromosomes":[265],"(enrichment":[266,388],"ratio":[267,389],">0,":[268,390],"adjusted":[269,391],"Integration":[273],"scATAC-seq":[275],"scRNA-seq":[277],"enabled":[278],"regulatory":[280],"network":[281],"inference.":[282],"RAD21,":[283],"core":[285],"component":[286],"cohesin":[289,470],"complex,":[290,471],"was":[291],"identified":[292,348,452],"as":[293,337,476],"key":[295],"regulator":[296],"binding":[298],"987":[300],"resistance-specific":[301],"regions":[303],"regulating":[305],"816":[306],"genes,":[307],"potentially":[308],"Simulated":[316],"silico":[318],"knockout":[319],"RAD21":[321,336,467],"random":[324],"forest":[325],"model":[326,401],"shifted":[327],"cells":[329],"toward":[330],"sensitive-like":[332],"state,":[334],"supporting":[335],"candidate":[339],"target":[341],"Additionally,":[346],"stem-like":[350,421,474],"malignant":[351],"population":[354],"enriched":[355],"samples,":[358],"displaying":[359],"features":[360,384],"metabolic":[362,386,430],"epithelial-mesenchymal":[365],"transition.":[366],"Within":[367],"population,":[369],"two":[370],"distinct":[371],"subclusters":[372],"emerged.":[373],"Cluster":[374],"1":[375],"epithelial-like,":[377],"progenitor-associated,":[378],"while":[379],"cluster":[380],"2":[381],"mesenchymal-like":[383],"dysregulation":[387],"This":[395],"aligns":[396],"recently":[399],"proposed":[400],"published":[402],"Nature":[404],"describing":[405],"continuum,":[408],"which":[410],"treatment-resistant":[411],"tumors":[412],"are":[413],"not":[414],"static":[415],"but":[416],"contain":[417],"range":[419],"states":[422],"varying":[424],"degrees":[425],"lineage":[427],"flexibility.":[431],"Conclusion":[432],"summary,":[434],"our":[435],"study":[436],"presents":[437],"first":[439],"longitudinal":[440],"characterization":[443],"patients.":[450,462],"coordinated":[453],"remodeling":[457],"during":[458],"evolution":[460],"across":[461],"highlight":[466],"along":[472],"heterogeneity,":[475],"potential":[477],"drivers":[478]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-12-04T00:00:00"}